Case number 1:18-cv-00227
Forest Laboratories Holdings, Ltd. et al v. Mylan Pharmaceuticals Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Dec 27, 2018 | 17 | Order Dismissing Case (6) Docket Text: STIPULATION AND ORDER: This Stipulation And Order shall finally resolve the Action. All other claims, defenses, and counterclaims asserted by the parties against each other in Plaintiffs' and Mylan's pleadings in the Action, including the allegations and averments contained therein, are hereby dismissed, without prejudice. Signed by Senior Judge Irene M. Keeley on 12/27/2018. (wrr) |
| Dec 27, 2018 | 18 | Report Re: Patent/Trademark (1) Docket Text: REPORT to USPTO on the filing or determination of an action regarding re [17] Order Dismissing Case. Copy to Trademark/Patent Office. (wrr) |
| Dec 24, 2018 | 16 | Stipulation of Dismissal (6) Docket Text: STIPULATION of Dismissal and Order by Mylan Pharmaceuticals Inc.. (O'Brien, William) |
| Dec 21, 2018 | 15 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by James F. Companion on behalf of All Plaintiffs (Companion, James) |
| Dec 20, 2018 | 13 | Notice of Appearance (2) Docket Text: NOTICE of Appearance by Gordon H. Copland on behalf of Mylan Pharmaceuticals Inc. (Copland, Gordon) |
| Dec 20, 2018 | 14 | Order (1) Docket Text: ORDER SCHEDULING STATUS CONFERENCE: It is ORDERED that the Court SCHEDULES a Status Conference for 1/24/2019 01:30 PM in Judge Keeley Chambers before Senior Judge Irene M. Keeley. Signed by Senior Judge Irene M. Keeley on 12/20/18. (cnd) |
| Dec 19, 2018 | 11 | Case Transferred In - District Transfer (3) |
| Dec 19, 2018 | N/A | Case Transferred Out to Another District (0) Docket Text: Case transferred to the United States District Court for the Northern District of West Virginia, Clarksburg Division. (nms) [Transferred from Delaware on 12/19/2018.] |
| Dec 19, 2018 | 10 | Order (4) Docket Text: SO ORDERED re (D.I. 270 in 16-cv-1114-RGA; D.I. 9 in 18-cv-482-RGA) Stipulation and Order. Signed by Judge Richard G. Andrews on 12/19/2018. Associated Cases: 1:16-cv-01114-RGA, 1:18-cv-00482-RGA(nms) [Transferred from Delaware on 12/19/2018.] |
| Dec 19, 2018 | 11 | *Restricted* (3) |
| Dec 19, 2018 | 12 | Notice of Verification of Attorney Admission (1) Docket Text: VERIFICATION OF ATTORNEY ADMISSION to Attorneys Blumenfeld, Poff and Vrana re [11] Case Transferred In - District Transfer. (cnd) |
| Dec 19, 2018 | 11 | Main Document Public Docket Sheet (3) Docket Text: Case transferred in from District of Delaware; Case Number 1:18-cv-00482. (cnd) |
| Dec 18, 2018 | 9 | Stipulation (4) Docket Text: STIPULATION and Proposed Order, by Mylan Pharmaceuticals Inc.. (Vrana, Robert) Modified on 12/19/2018 (nms). [Transferred from Delaware on 12/19/2018.] |
| Aug 30, 2018 | N/A | Calendar Entry (0) Docket Text: CORRECTING ENTRY: The stipulation filed at D.I. 9 has been removed per the directive at D.I. [8]. (nms) [Transferred from Delaware on 12/19/2018.] |
| Apr 13, 2018 | 7 | Stipulation (4) Docket Text: STIPULATION and Order of Consolidation by Allergan Sales, LLC, Allergan USA, Inc., Forest Laboratories Holdings, Ltd., Ironwood Pharmaceuticals, Inc., Allergan Sales LLC. (Noreika, Maryellen) [Transferred from Delaware on 12/19/2018.] |
| Apr 13, 2018 | 8 | Order (4) Docket Text: SO ORDERED Granting (7 in 18-cv-482-RGA, 151 in 16-cv-1114-RGA) Stipulation and Order of Consolidation. Signed by Judge Richard G. Andrews on 4/13/2018. Associated Cases: 1:16-cv-01114-RGA, 1:18-cv-00482-RGA(nms)[Transferred from Delaware on 12/19/2018.] |
| Apr 4, 2018 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) [Transferred from Delaware on 12/19/2018.] |
| Apr 4, 2018 | 6 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Forest Laboratories Holdings, Ltd., Allergan USA, Inc., Allergan Sales, LLC, Ironwood Pharmaceuticals, Inc.. Mylan Pharmaceuticals Inc. served on 4/4/2018, answer due 4/25/2018. (Noreika, Maryellen)[Transferred from Delaware on 12/19/2018.] |
| Mar 29, 2018 | N/A | * (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Mylan Pharmaceuticals Inc. on 3/29/2018. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (crb) [Transferred from Delaware on 12/19/2018.] |
| Mar 29, 2018 | 1 | Complaint (10) |
| Mar 29, 2018 | 1 | Exhibit A - G (496) |
| Mar 29, 2018 | 1 | Civil Cover Sheet (1) |
| Mar 29, 2018 | 2 | Other Document (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (crb) [Transferred from Delaware on 12/19/2018.] |
| Mar 29, 2018 | 3 | Other Document (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 2/14/2018. Date of Expiration of Patent: See Attachment.Thirty Month Stay Deadline: 8/14/2020. (crb)[Transferred from Delaware on 12/19/2018.] |
| Mar 29, 2018 | 4 | Report Re: Patent/Trademark (2) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,304,036 B2; 7,371,727 B2; 7,704,947 B2; 7,745,409 B2; 8,080,526 B2. (crb) [Transferred from Delaware on 12/19/2018.] |
| Mar 29, 2018 | 5 | Corporate Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Allergan plc (f/k/a Actavis plc) for Allergan Sales, LLC, Allergan USA, Inc., Forest Laboratories Holdings, Ltd. filed by Allergan Sales, LLC, Allergan USA, Inc., Forest Laboratories Holdings, Ltd., Ironwood Pharmaceuticals, Inc. (crb) [Transferred from Delaware on 12/19/2018.] |
| Mar 29, 2018 | 1 | Main Document (10) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed against Mylan Pharmaceuticals Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2351026.) - filed by Forest Laboratories Holdings, Ltd., Allergan USA, Inc., Allergan Sales, LLC, Ironwood Pharmaceuticals, Inc. (Attachments: # (1) Exhibit A - G, # (2) Civil Cover Sheet)(crb) [Transferred from Delaware on 12/19/2018.] |
